J&J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch
Shots:
- The MHLW has approved Acuvue Theravision with Ketotifen as the first combination contact lens that provides vision correction and an antihistamine drug to relieve symptoms for people experiencing itchy allergy eyes
- Data demonstrated that 8 out of 10 contact lens wearers feel frustrated when their eye allergies interfere with normal contact lens wear. The products may help patients to wear contact lenses during the allergy season
- Acuvue Theravision with Ketotifen marks the first regulatory approval by any health authority while the company is working with authorities globally to bring novel technology to lens wearer
Ref: PRNewswire | Image: Drug Dangers
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com